111C Chervoneva, Inna - Thomas Jefferson University - Thomas Jefferson University
ixc107

Inna Chervoneva, PhD

Contact Dr. Chervoneva

1015 Chestnut Street
Suite M-100 Mezzanine
Philadelphia, PA 19107

(215) 955-4083
(215) 503-3804 fax

Most Recent Peer-reviewed Publications

  1. Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression
  2. Robust estimation of the parameters of g-and-h distributions, with applications to outlier detection
  3. Estimation of nonlinear differential equation model for glucose-insulin dynamics in type I diabetic patients using generalized smoothing
  4. Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty
  5. Prolactin-Stat5 signaling in breast cancer is potently disrup 18AF ted by acidosis within the tumor microenvironment
  6. Analyzing the ingredients of a telephone counseling intervention for traumatic brain injury
  7. Two-stage hierarchical modeling for analysis of subpopulations in conditional distributions
  8. Conversion from enzyme-inducing antiepileptic drugs to topiramate: Effects on lipids and c-reactive protein
  9. Erratum: Major and minor depression after traumatic brain injury (Archives of Physical Medicine and Rehabilitation (2011) 92 (1211-1219))
  10. Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma
  11. Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone
  12. The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
  13. Major and minor depression after traumatic brain injury
  14. Tumor-derived interleukin-10 as a prognostic factor in stage III patients undergoing adjuvant treatment with an autologous melanoma cell vaccine
  15. Constrained S-estimators for linear mixed effects models with covariance components
  16. A phase i trial of samarium-153-lexidronam complex for treatment of clinically nonmetastatic high-risk prostate cancer: First report of a completed study
  17. Latency to first seizure after temporal lobectomy predicts long-term outcome
  18. Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence
  19. Selection of optimal reference genes for normalization in quantitative RT-PCR
  20. Rabies virus-based vaccines elicit neutralizing antibodies, poly-functional CD8+ T cell, and protect rhesus macaques from AIDS-like disease after SIVmac251 challenge
0